INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

ITI Pharma and Healthcare Fund - Regular Plan - Growth

NAVs of 6 Nov 2026

ITI Mutual Fund · Equity fund · Regular plan · Growth

Sectoral / ThematicRegular · GrowthRisk: Very High
NAV · 5 Nov 2026
₹18.0986 ▲ 0.52%
ITI Mutual Fund
Fund size₹266 crJuly - September 2026
1-month range₹16.59 – 18.10
1 year+10.11%rank 50 of 271
Expense ratio2.57%regular plan, a year
5 years–a year

What the fund does

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

BenchmarkNifty Healthcare Total Return Index
Fund houseITI Mutual Fund
Fund managersAnimesh Singhsince 8 May 2026Nilay Dalalsince 8 May 2026

NAV history

171818 2026-08-112026-08-242026-09-042026-09-182026-10-012026-10-152026-10-29

Returns

1 week
+3.53%avg 4.4%
1 month
+2.58%avg 2.1%
3 months
-0.04%avg -2.3%
6 months
+9.22%avg 2.6%
This year
+15.33%avg 3.0%
1 year
+10.11%avg 2.6% · #50/271
3 years (a year)
+18.69%avg 13.7% · #28/160

Bars: this plan; the thin mark is the Sectoral / Thematic average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+0.7
2025-7.9-8.1+7.3+0.7+1.0+2.5+2.2-4.1-1.6+3.6-0.7-3.1
2026-6.5+5.4-4.8+8.1+3.6+5.1+3.5+2.7-4.2-0.1+2.6

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Risk

Volatility13.7%yearly, from daily NAVs
Worst fall-17.19%3 Jan 2025 → 29 Jan 2026
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 30 Nov 2021).

Fund details

Fund size (average AUM, July - September 2026)₹266 cr across all plans · this plan ₹242 cr
Fund houseITI Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.86% · Regular 2.57% (5 Nov 2026)
Exit loadIf redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL
Minimum investment₹5,000 · additional ₹1,000
Scheme code (AMFI)149270
ISININF00XX01BL5
NAV date5 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · Growth₹19.9767+12.10%
Direct · IDCW₹19.9744+12.09%
Regular · IDCW₹18.0986+10.11%

Top Sectoral / Thematic funds (regular plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+47.19%+43.51%
HDFC Defence Fund+17.69%+34.19%
HDFC Pharma and Healthcare Fund+24.81%+29.79%
SBI HEALTHCARE OPPORTUNITIES FUND+19.79%+24.25%
HDFC Transportation and Logistics Fund+7.84%+24.00%
UTI - Healthcare Fund+16.17%+23.25%
Mirae Asset Healthcare Fund+20.29%+22.85%
BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUND+14.95%+22.27%
ITI Pharma and Healthcare Fund+10.11%+18.69%

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth today?

₹18.0986 as of 5 Nov 2026, from AMFI's official NAV data.

What are the returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth?

1 year: 10.11%, 3 years: 18.69% a year

How does ITI Pharma and Healthcare Fund rank in its category?

50 of 271 Sectoral / Thematic funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.